UBS’s BioTelemetry, Inc. BEAT Stock Holding History

UBS’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$385K	Sell	57,376 -13,949	-20%	-$97.8K	﹤0.01%	4535
2014 Q2	$512K	Sell	71,325 -52,641	-42%	-$419K	﹤0.01%	4201
2014 Q1	$1.25M	Buy	123,966 +61,098	+97%	+$562K	﹤0.01%	3264
2013 Q4	$499K	Buy	62,868 +35,916	+133%	+$335K	﹤0.01%	4347
2013 Q3	$267K	Sell	26,952 -28,563	-51%	-$225K	﹤0.01%	4839
2013 Q2	$328K	Buy	+55,515	New	+$187K	﹤0.01%	4546

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

CPIM

Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

UBS's BEAT Position: Q3 2014 in Review

UBS reduced its BioTelemetry, Inc. (BEAT) stake by 20% in Q3 2014, selling an estimated $97.8K and leaving 57,376 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #4535.

UBS first reported a position in BEAT in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.25M in Q1 2014. 85 funds tracked by Wall St. Rank hold BEAT as of Q3 2014.

UBS held 57,376 shares of BioTelemetry, Inc. worth $385K as of Q3 2014.
UBS sold 13,949 BioTelemetry, Inc. shares in Q3 2014, an estimated $97.8K.
BioTelemetry, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4535 holding.
UBS first reported a position in BioTelemetry, Inc. in Q2 2013 and has held it in 6 quarters since.
UBS's BioTelemetry, Inc. position peaked at $1.25M in Q1 2014.
85 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.